The knowledge-space dynamic in the UK bioeconomy

Area

Volumn 41, Issue 3, 2009, Pages 273-284

  Birch, Kean ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Bioeconomy; Biotechnology innovation; Knowledge space dynamic; Quantitative analysis; Regional concentrations; UK

Indexed keywords

BIOTECHNOLOGY; EMPLOYMENT; INNOVATION; KNOWLEDGE; MANUFACTURING; QUANTITATIVE ANALYSIS;

EURASIA; EUROPE; UNITED KINGDOM; WESTERN EUROPE;

EID: 68749117678     PISSN: 00040894     EISSN: 14754762     Source Type: Journal    
DOI: 10.1111/j.1475-4762.2008.00864.x     Document Type: Article

References (75)

1. ACARD, ABRC and The Royal Society 1980 Biotechnology: Report of a joint working party [aka The Spinks Report]HMSO, London
2. Acharya R, Arundel A and Orsenigo L 1998 The evolution of European biotechnology and its future competitiveness in
3. Senker J ed Biotechnology and competitive advantage Edward Elgar, Cheltenham 89-109
4. Acs Z, Audretsch D and Feldman M 1991 Real effects of academic research: comment American Economic Review 82 363-7
5. Asheim B and Coenen L 2006 The role of regional innovation systems in a globalising economy in
6. Vertova G ed The economic geography of globalization Routledge, Oxford 148-65
7. Audretsch D and Feldman M 1996 R&D spillovers and the geography of innovation and production American Economic Review 86 630-40
8. Audretsch D and Stephan P 1996 Company-scientist locational links: The case of biotechnology American Economic Review 86 641-52
9. Audretsch D and Stephan P 1999 Knowledge spillovers in biotechnology: sources and incentives Journal of Evolutionary Economics 9 97-107
10. Bagchi-Sen S 2007 Strategic considerations for innovation and commercialization in the US biotechnology sector European Planning Studies 15 753-66
11. Bartholomew S 1996 National systems of biotechnology innovation: Complex interdependence in the global system Journal of International Business Studies 28 241-66
12. Bathelt H, Malmberg A and Maskell P 2004 Clusters and knowledge: Local buzz, global pipelines and the process of knowledge creation Progress in Human Geography 28 31-56
13. Bibby K, Davis J and Jones C 2003 Biopharmaceuticals - moving to centre stage BioPeople
14. BIGT 2003 Improving national health, improving national wealth Bioscience Innovation and Growth Team, London
15. Birch K 2006 Biotechnology value chains as a case study of the knowledge economy: The relationship between knowledge, space and technology Unpublished PhD thesis Department of Planning, Oxford Brookes University
16. Birch K 2007a Knowledge, space and biotechnology Geography Compass 1 1097-117
17. Birch K 2007b The knowledge-space dynamic in the British biotechnology industry: Function, relation, and association in Cooke P and Schwartz D eds Creative regions: Technology, culture and knowledge entrepreneurship Routledge, London 148-68
18. Birch K 2008 Alliance-driven governance: Applying a global commodity chains approach to the UK biotechnology industry Economic Geography 84 83-103
19. Breschi S, Lissoni F and Orsenigo L 2003 Success and failure in the development of biotechnology clusters: The case of Lombardy in
20. Fuchs G ed Comparing the development of biotechnology clusters Harwood Academic, London 143-68
21. Chakrabarti A and Weisenfeld U 1991 An empirical analysis of innovation strategies of biotechnology firms in the US Journal of Engineering and Technology Management 8 243-60
22. Chesbrough H 2003 Open innovation Harvard Business School Press, Boston MA
23. Coenen L, Moodysson J and Asheim B 2004 Nodes, networks and proximities: on the knowledge dynamics of the Medicon Valley Biotech Cluster European Planning Studies 12 1003-18
24. Cooke P 2001 Biotechnology clusters in the UK: Lessons from localisation in the commercialisation of science Small Business Economics 17 43-59
25. Cooke P 2003 The evolution of biotechnology in three continents: Schumpeterian or Penrosian? European Planning Studies 11 757-63
26. Cooke P 2004a The molecular biology revolution and the rise of bisocience megacentres in North America and Europe Environment and Planning C 22 161-77
27. Cooke P 2004b Regional knowledge capabilities, embeddedness of firms and industry organisation: Bioscience megacentres and economic geography European Planning Studies 12 625-41
28. Cooke P 2005 Regionally asymmetric knowledge capabilities and open innovation: Exploring 'globalisation 2'-a new model of industry organisation Research Policy 34 1128-49
29. Cooke P 2006 Global bioregions: Knowledge domains, capabilities and innovation system networks Industry and Innovation 13 437-58
30. Cooke P 2007 Growth cultures: The global bioeconomy and its bioregions Routledge, London
31. Cooke P, Uranga M and Extebarria G 1998 Regional systems of innovation: an evolutionary perspective Environment and Planning A 30 1563-84
32. Coriat B, Orsi F and Weinstein O 2003 Does biotech reflect a new science-based innovation regime? Industry and Innovation 10 231-53
33. Critical I 2005 Biotechnology in Europe: 2005 comparative study EuropaBio, Brussels
34. Deeds D and Hill C 1996 Strategic alliances and the rate of new product development: An empirical study of entrepreneurial biotechnology firms Journal of Business Venturing 11 41-55
35. DTI 1999a Biotechnology clusters Report Department of Trade and Industry, London
36. DTI 1999b Genome valley report Department of Trade and Industry, London
37. EC 2005 New perspectives on the knowledge-based bio-economy: Conference report European Commission, Brussels
38. EC 2007 Mid term review of the strategy on life sciences and biotechnology [SEC (2007) 441]European Commission, Brussels
39. Ernst & Young 2003 Beyond borders Ernst & Young International Ltd, London
40. Ernst & Young 2007 Sustained progress: The European perspective Ernst & Young International Ltd, London
41. Etzkowitz H and Leydesdorff L 2000 The dynamics of innovation: From national systems and 'mode 2' to a triple helix of university-industry-government relations Research Policy 29 109-23
42. Feldman M 1999 The new economics of innovation, spillovers and agglomeration: A review of empirical studies Economic Innovation and New Technology 8 5-25
43. Feldman M 2003 The locational dynamics of the US biotech industry: knowledge externalities and the anchor hypothesis Industry and Innovation 10 311-28
44. Feldman M and Francis J 2003 Fortune favours the prepared region: The case of entrepreneurship in the Capitol region biotechnology cluster European Planning Studies 11 765-88
45. Gertler M and Levitte Y 2005 Local nodes in global networks: The geography of knowledge flows in biotechnology innovation Industry and Innovation 12 487-507
46. Kaiser R 2003 Multi-level science policy and regional innovation: The case of the Munich cluster for pharmaceutical biotechnology European Planning Studies 11 841-57
47. Kasabov E and Delbridge R 2008 Innovation, embeddedness and policy: evidence from life sciences in three UK regions Technology Analysis & Strategic Management 20 185-200
48. Lawrence S 2007 State of the biotech sector -2006 Nature Biotechnology 25 706
49. Lawrence S 2008 State of the biotech sector -2007 Nature Biotechnology 26 728
50. Leibovitz J 2004 'Embryonic' knowledge-based clusters and cities: The case of biotechnology in Scotland Urban Studies 41 1133-55
51. Malmberg A and Maskell P 2002 The elusive concept of localization economies: Towards a knowledge-based theory of spatial clustering Environment and Planning A 34 429-49
52. Malmberg A and Power D 2005 (How) do (firms in) clusters create knowledge? Industry and Innovation 12 409-31
53. Moodysson J, Coenen L and Asheim B 2008 Explaining spatial patterns of innovation: Analytical and synthetic modes of knowledge creation in the Medicon Valley life-science cluster Environment and Planning A 40 1040-56
54. OECD 2006 The bioeconomy to 2030: Designing a policy agenda Organisation for Economic Co-operation and Development, Paris
55. Pisano G 2006 Can science be a business? Lessons from biotech Harvard Business Review 84 114-25
56. Porter M 1990 The competitive advantage of nations Macmillan, London
57. Powell W 1998 Learning from collaboration: Knowledge and networks in the biotechnology and pharmaceutical industries California Management Review 40 228-40
58. Powell W, Koput K and Smith-Doerr L 1996 Interorganizational collaboration and the locus of innovation: Networks of learning in biotechnology Administrative Science Quarterly 41 116-45
59. Powell W, Koput K, Bowie J and Smith-Doerr L 2002 The spatial clustering of science and capital: Accounting for biotech firm-venture capital relationships Regional Studies 36 291-305
60. Prevezer M 2003 The development of biotechnology clusters in the USA from the late 1970s to the early 1990s in
61. Fuchs G ed Biotechnology in comparative perspective Routledge, London 33-55
62. Rajan K S 2006 Biocapital Duke University Press, Durham NC
63. Ryan C and Phillips P 2004 Knowledge management in advanced technology industries: An examination of international agricultural biotechnology clusters Environment and Planning C 22 217-32
64. Saviotti P, Joly P-B, Estades J, Ramani S and de Looze M-A 1998 The creation of European dedicated biotechnology firms in
65. Senker J ed Biotechnology and competitive advantage Edward Elgar, Cheltenham 68-87
66. Senker J 2005 Biotechnology alliances in the European pharmaceutical industry: Past, present and future SEWPS paper 137 SPRU, University of Sussex
67. Senker J, Joly P-B and Reinhard M 1996 Overseas biotechnology research by Europe's chemical/pharmaceutical multinationals: Rationale and implications STEEP discussion paper 33 SPRU, University of Sussex
68. US Congress House Committee on Science and Technology 1981 Commercialization of academic biomedical research, hearings before the subcommittee on investigations and oversight, June 8-9 Government Printing Office, Washington DC
69. Woiceshyn J 1995 Lessons in product innovation: A case study of biotechnology firms R&D Management 25 395-409
70. Zeller C 2001 Clustering biotech: A recipe for success? Spatial patterns of growth of biotechnology in Munich, Rhineland and Hamburg Small Business Economics 17 123-41
71. Zeller C 2004 North Atlantic innovative relations of Swiss pharmaceuticals and the proximities with regional biotech arenas Economic Geography 80 83-111
72. Zeller C 2008 From the gene to the globe: Extracting rents based on intellectual property monopolies Review of International Political Economy 15 86-115
73. Zika E, Paptryfon I, Wolf O, Gomez-Barbero M, Stein A and Bock A-K 2007 Consequences, opportunities and challenges of modern biotechnology for Europe [aka Bio4EU Study] Joint Research Centre - European Commission, Luxembourg
74. Zucker L, Darby M and Brewer M 1998 Intellectual human capital and the birth of US biotechnology enterprises American Economic Review 88 291-306
75. Zucker L, Darby M and Armstrong J 2002 Commercializing knowledge: university science, knowledge capture, and firm performance in biotechnology Management Science 48 138-53